Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Merck
Colorcon
McKinsey
Dow

Last Updated: May 19, 2022

FLECTOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Flector patents expire, and what generic alternatives are available?

Flector is a drug marketed by Inst Biochem and is included in one NDA.

The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.

Drug patent expirations by year for FLECTOR
Drug Prices for FLECTOR

See drug prices for FLECTOR

Drug Sales Revenue Trends for FLECTOR

See drug sales revenues for FLECTOR

Paragraph IV (Patent) Challenges for FLECTOR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FLECTOR Topical Patch diclofenac epolamine 1.3% 021234 1 2015-06-26

US Patents and Regulatory Information for FLECTOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Inst Biochem FLECTOR diclofenac epolamine SYSTEM;TOPICAL 021234-001 Jan 31, 2007 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FLECTOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Inst Biochem FLECTOR diclofenac epolamine SYSTEM;TOPICAL 021234-001 Jan 31, 2007 See Plans and Pricing See Plans and Pricing
Inst Biochem FLECTOR diclofenac epolamine SYSTEM;TOPICAL 021234-001 Jan 31, 2007 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for FLECTOR

See the table below for patents covering FLECTOR around the world.

Country Patent Number Title Estimated Expiration
South Korea 960003327 See Plans and Pricing
Italy 8622320 See Plans and Pricing
Canada 1303050 SEL DE DICLOFENAC ET D'UNE BASE ORGANIQUE CYCLIQUE, ET COMPOSITIONS PHARMACEUTIQUES QUI EN CONTIENNENT (SALT OF DICLOFENAC WITH A CYCLIC ORGANIC BASE AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT) See Plans and Pricing
Canada 2121065 PREPARATION POUR PLATRE EXTERNE ANTI-INFLAMMATOIRE ET ANALGESIQUE (EXTERNAL ANTI-INFLAMMATORY AND ANALGESIC PLASTER PREPARATION) See Plans and Pricing
Denmark 592987 See Plans and Pricing
Australia 8117587 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
AstraZeneca
Baxter
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.